Fund Holdings — Commodore Capital LP

Total Portfolio Value:
$1.14B
Total Bought:
$358.62M
Total Sold:
$157.27M
Net Transaction:
+$201.35M
Notable People:
Michael Jonathan Kramarz, Robert Egen Turrell Atkinson, Commodore Capital Gp Llc
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Merus N V4,428,0724,747,373+319,301$104.41M$130.55M11.41%+$26.14M
Xenon Pharmaceuticals Inc.(XENE)1,845,0002,167,793+322,793$63.03M$99.85M8.72%+$36.82M
Nuvalent Inc828,7781,331,037+502,259$38.10M$97.95M8.56%+$59.85M
Vera Therapeutics, Inc.CL A(VERA)5,450,0005,450,0000$74.72M$83.82M7.32%+$9.10M
Rhythm Pharmaceuticals, Inc.(RYTM)2,075,0001,550,000-525,000$47.57M$71.25M6.23%+$23.68M
Vaxcyte, Inc.(PCVX)1,100,0001,100,0000$56.08M$69.08M6.04%+$13.00M
Cabaletta Bio, Inc.(CABA)2,525,7531,900,000-625,753$38.44M$43.13M3.77%+$4.69M
Immunovant, Inc.(IMVT)1,000,0001,000,0000$38.39M$42.13M3.68%+$3.74M
Viridian Therapeutics, Inc.(VRDN)2,200,0001,924,074-275,926$33.75M$41.91M3.66%+$8.16M
Arvinas, Inc.(ARVN)01,000,000+1,000,000$0$41.16M3.60%+$41.16M
Spyre Therapeutics, Inc.(SYRE)116,3241,884,084+1,767,760$1.42M$40.55M3.54%+$39.12M
Enliven Therapeutics Inc2,901,8162,901,8160$39.64M$40.16M3.51%+$522.3K
Cogent Biosciences, Inc.(COGT)5,566,0265,566,0260$54.27M$32.73M2.86%-$21.54M
Alpine Immune Sciences Inc1,325,0001,610,000+285,000$15.17M$30.69M2.68%+$15.52M
Soleno Therapeutics Inc887,500700,000-187,500$26.19M$28.18M2.46%+$1.98M
Celldex Therapeutics, Inc.(CLDX)706,665701,967-4,698$19.45M$27.84M2.43%+$8.39M
Celcuity Inc.(CELC)1,694,1411,754,704+60,563$15.48M$25.57M2.23%+$10.08M
Rayzebio Inc288,911383,638+94,727$6.41M$23.85M2.08%+$17.44M
Pharvaris N V
COM
0800,000+800,000$0$22.44M1.96%+$22.44M
C4 Therapeutics, Inc.(CCCC)03,800,000+3,800,000$0$21.47M1.88%+$21.47M
ABIVAX Société AnonymeADS(ABVX)01,895,003+1,895,003$0$20.28M1.77%+$20.28M
Nkarta, Inc.(NKTX)02,730,000+2,730,000$0$18.02M1.57%+$18.02M
Kura Oncology, Inc.(KURA)1,400,0001,248,062-151,938$12.77M$17.95M1.57%+$5.18M
Harpoon Therapeutics Inc01,500,000+1,500,000$0$17.05M1.49%+$17.05M
Akero Therapeutics Inc565,000565,0000$28.58M$13.19M1.15%-$15.38M
Dyne Therapeutics, Inc.(DYN)0900,000+900,000$0$11.97M1.05%+$11.97M
Vistagen Therapeutics, Inc.(VTGN)1,575,0001,575,0000$8.25M$8.10M0.71%-$157.5K
Third Harmonic Bio Inc1,700,000706,706-993,294$10.86M$7.75M0.68%-$3.11M
Adverum Biotechnologies Inc10,000,00010,000,0000$15.00M$7.53M0.66%-$7.47M
Apogee Therapeutics Inc250,000250,0000$5.33M$6.99M0.61%+$1.66M
SAB Biotherapeutics, Inc.(SABS)01,831,746+1,831,746$0$1.26M0.11%+$1.26M
Dbv Technologies S AADR92,68792,6870$126.1K$88.3K0.01%-$37.7K
AMBRX BIOPHARMA INCSPONSORED ADS3,518,5560-3,518,556$40.46M$0—-$40.46M
CRINETICS PHARMACEUTICALS INCOM(CRNX)500,0000-500,000$14.87M$0—-$14.87M
DAY ONE BIOPHARMACEUTICALS ICOM
COM
739,6610-739,661$9.08M$0—-$9.08M
IDEAYA BIOSCIENCES INCCOM(IDYA)775,0000-775,000$20.91M$0—-$20.91M
MERSANA THERAPEUTICS INCCOM2,244,3780-2,244,378$2.85M$0—-$2.85M
SYNDAX PHARMACEUTICALS INCCOM(SNDX)957,5090-957,509$13.90M$0—-$13.90M
Page 1 of 1
Commodore Capital LP — 13F Holdings — Q4 2023 | TickerTrail